ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
ASCO 2022 on the rEECur Trial: High-Dose Ifosfamide as a SoC for Recurrent and Primary Refractory Ewing Sarcoma
By
ecancer
FEATURING
Martin Mccabe
By
ecancer
FEATURING
Martin Mccabe
Login to view comments.
Click here to Login
